Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2000
06/15/2000CA2350888A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction
06/15/2000CA2350887A1 Non-peptide antagonists of glp-1 receptor and methods of use
06/15/2000CA2350590A1 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
06/15/2000CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000CA2326842A1 Micronized eplerenone compositions
06/15/2000CA2319435A1 Triazolo derivatives and chemokine inhibitors containing the same as effective component
06/15/2000CA2317025A1 Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
06/14/2000EP1007717A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
06/14/2000EP1007715A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
06/14/2000EP1007695A2 Rab proteins
06/14/2000EP1007679A1 Recombinant human erythropoietin with advantageous glycosylation profile
06/14/2000EP1007678A1 Kringle1
06/14/2000EP1007677A2 Protease-related protein
06/14/2000EP1007674A1 Testis-specific transcription factor zgcl-1
06/14/2000EP1007673A1 Novel bone mineralization proteins, dna, vectors, expression systems
06/14/2000EP1007672A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
06/14/2000EP1007665A1 Two human homologues of galectin-5
06/14/2000EP1007664A1 Therapies involving mutated heat shock transcription factor
06/14/2000EP1007661A2 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007652A1 Transgenic animals with knocked-in vec receptor genes and uses thereof
06/14/2000EP1007632A1 Isolation of bone and cartilage precursor cells
06/14/2000EP1007569A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE $g(a)-GALACTOSYL EPITOPE
06/14/2000EP1007567A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules
06/14/2000EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
06/14/2000EP1007561A2 Novel conjugates of opioids and endogenous carriers
06/14/2000EP1007556A2 Troponin subunits and fragments useful as angiogenesis inhibitors
06/14/2000EP1007543A1 A method for stimulating red blood cell production
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007537A1 Receptor protein designated 2f1
06/14/2000EP1007534A1 Bh3 interacting domain death agonist
06/14/2000EP1007518A1 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
06/14/2000EP1007514A1 Heterocyclic ketones as npy y5 antagonists
06/14/2000EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
06/14/2000EP1007504A1 Sterilized 5-aminolevulinic acid
06/14/2000EP1007087A1 INDUCTION OF CTLs SPECIFIC FOR NATURAL ANTIGENS BY CROSS-PRIMING IMMUNIZATION
06/14/2000EP1007085A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity
06/14/2000EP1007076A1 Method of antagonizing the human src sh2 domain
06/14/2000EP1007072A1 Glial cell line-derived neurotrophic factor receptors
06/14/2000EP1007071A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist
06/14/2000EP1007068A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
06/14/2000EP1007063A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells
06/14/2000EP1007055A1 Methods for the administration of amifostine
06/14/2000EP1007051A1 Integrin receptor antagonists
06/14/2000EP1007047A1 Use of mizolastine for preparing a medicine for treating inflammation
06/14/2000EP1007044A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/14/2000EP1007034A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007026A1 Integrin antagonists
06/14/2000EP1007025A1 Use of hydroxyguanidines
06/14/2000EP1007010A2 Pharmaceutical composition comprising an azasteroid
06/14/2000EP0901463B1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
06/14/2000EP0746326A4 Oligomeric compounds having nitrogen-containing linkages
06/14/2000CN1256691A 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
06/14/2000CN1256687A Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP
06/14/2000CN1256629A Therapeutic compositions
06/14/2000CN1256617A Feed coposition for broilers and method for breeding broilers
06/14/2000CN1256276A Intermediate of beta 3-adrenalin energy receptor protagonist and its synthesis method
06/14/2000CN1053451C Novel peptide compound with therapeutic active in blood coagulation reaction, its prep. and pharmaceutical composition thereof
06/14/2000CN1053441C Compound with 1-(aryl china olefine)-4-(aryl methyl) piperazine structure, its preparation process and medicine containing the compound thereof
06/14/2000CN1053438C Benzodiazepin-2-one derivatives, process for their prepn. and pharmaceutical composition containing them
06/14/2000CN1053381C Drug for promoting puerperal physiological recovery and curing postpartum disease
06/14/2000CN1053362C Baicaoshengshou oral liquid and its prep.
06/14/2000CN1053356C Kidney-tonifying and life-prolonging wine
06/13/2000US6075151 Inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related hyperlipidemia, cardiovascular disorders
06/13/2000US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents
06/13/2000US6075119 Particles useful in the prevention and treatment of staphylococcal or streptococcal infection
06/13/2000US6075034 Spiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivatives
06/13/2000US6075014 Inhibitors of β-lactamases and uses therefor
06/13/2000US6074873 Nucleic acids encoding NL-3
06/13/2000US6074848 Amino acid sequence; for antiproliferative and wound healing agents
06/13/2000US6074841 Don-1 gene and polypeptides and uses therefor
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000US6074666 Liposome compositions of porphyrin photosensitizers
06/13/2000US6074635 T cell activation
06/13/2000CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
06/13/2000CA2107014C Therapeutic agent for parkinson's disease
06/13/2000CA2030732C Thiophene derivatives; process for preparing the same and pharmaceutical compositions containing them
06/13/2000CA2014062C Pyridine derivatives
06/13/2000CA2003981C Pharmaceutical compositions and use thereof in the treatment of psoriasis
06/13/2000CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates
06/13/2000CA1341027C Phosphonoalkylpurine derivatives
06/13/2000CA1341025C Substituted silyl alkylene amines
06/13/2000CA1341023C Peptide derivatives
06/11/2000CA2292004A1 Cleanser composition
06/08/2000WO2000032816A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000WO2000032803A2 Novel nucleic acid transferring agents, compositions containing them and uses
06/08/2000WO2000032778A2 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
06/08/2000WO2000032768A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032620A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032590A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
06/08/2000WO2000032589A1 Eletriptan hydrobromide monohydrate
06/08/2000WO2000032587A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
06/08/2000WO2000032582A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000032578A1 Benzimidazole compounds that are vitronectin receptor antagonists
1 ... 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 ... 1564